The management of febrile neutropenia in the posaconazole era: a new challenge?

doi:10.3324/haematol.2012.062166

Editorial

. 2012 Jul;97(7):963-5.

doi: 10.3324/haematol.2012.062166.

The management of febrile neutropenia in the posaconazole era: a new challenge?

Livio Pagano, Morena Caira, Manuel Cuenca-Estrella

PMID: 22798545
PMCID: PMC3396663
DOI: 10.3324/haematol.2012.062166

Editorial

The management of febrile neutropenia in the posaconazole era: a new challenge?

Livio Pagano et al. Haematologica. 2012 Jul.

. 2012 Jul;97(7):963-5.

doi: 10.3324/haematol.2012.062166.

Authors

Livio Pagano, Morena Caira, Manuel Cuenca-Estrella

PMID: 22798545
PMCID: PMC3396663
DOI: 10.3324/haematol.2012.062166

No abstract available

PubMed Disclaimer

Cited by

The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study.
Özkocaman V, Özkalemkaş F, Seyhan S, Ener B, Ursavaş A, Ersal T, Kazak E, Demirdöğen E, Mıstık R, Akalın H. Özkocaman V, et al. Turk J Haematol. 2018 Nov 13;35(4):277-282. doi: 10.4274/tjh.2017.0430. Epub 2018 Jul 26. Turk J Haematol. 2018. PMID: 30047484 Free PMC article.
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).
Caira M, Candoni A, Verga L, Busca A, Delia M, Nosari A, Caramatti C, Castagnola C, Cattaneo C, Fanci R, Chierichini A, Melillo L, Mitra ME, Picardi M, Potenza L, Salutari P, Vianelli N, Facchini L, Cesarini M, De Paolis MR, Di Blasi R, Farina F, Venditti A, Ferrari A, Garzia M, Gasbarrino C, Invernizzi R, Lessi F, Manna A, Martino B, Nadali G, Offidani M, Paris L, Pavone V, Rossi G, Spadea A, Specchia G, Trecarichi EM, Vacca A, Cesaro S, Perriello V, Aversa F, Tumbarello M, Pagano L; SEIFEM Group (Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne). Caira M, et al. Haematologica. 2015 Feb;100(2):284-92. doi: 10.3324/haematol.2014.113399. Haematologica. 2015. PMID: 25638805 Free PMC article.
Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study.
Metan G, Çiftçioğlu A, Saba R, Kılıç AU, Özdemir K, Çağ Y, Ünal DK, Aksoy F, Berk H, Mert G, Tunçcan ÖG, Tombak A, Balkan İİ, Çavuş SA, Kandemir B, Mutlu B, İnkaya AÇ, Kaynar L, Atay MH, Dursun FE, Saydam G, Ünsal Y, Sarı SF, Akan H; Study group. Metan G, et al. Indian J Hematol Blood Transfus. 2025 Jan;41(1):75-88. doi: 10.1007/s12288-024-01790-2. Epub 2024 May 20. Indian J Hematol Blood Transfus. 2025. PMID: 39917507
Strategies for the management of invasive fungal infections due to filamentous fungi in high-risk hemato-oncological patients.
Vallejo C, Fortún J; Study Group for IFI management. Vallejo C, et al. Rev Esp Quimioter. 2019 Feb;32(1):31-39. Epub 2018 Dec 13. Rev Esp Quimioter. 2019. PMID: 30547501 Free PMC article.
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.
Hirade K, Kusumoto S, Hashimoto H, Shiraga K, Hagiwara S, Oiwa K, Suzuki T, Kinoshita S, Ri M, Komatsu H, Iida S. Hirade K, et al. Cancer Med. 2024 Feb;13(3):e6815. doi: 10.1002/cam4.6815. Epub 2024 Jan 11. Cancer Med. 2024. PMID: 38213090 Free PMC article.

See all "Cited by" articles

References

1. Caira M, Mancinelli M, Leone G, Pagano L. Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends. Med Mycol. 2011;49(Suppl 1):S13–6. - PubMed
1. Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L, et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality—SEIFEM-C Report. Clin Infect Dis. 2007;44(11):1524–5. - PubMed
1. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011;66(Suppl 1):i5–14. - PubMed
1. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis. 1995;171(6):1545–52. - PubMed
1. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;326(13):845–51. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Caira M, Mancinelli M, Leone G, Pagano L. Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends. Med Mycol. 2011;49(Suppl 1):S13–6. - PubMed

[2] Caira M, Mancinelli M, Leone G, Pagano L. Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends. Med Mycol. 2011;49(Suppl 1):S13–6. - PubMed

[3] Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L, et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality—SEIFEM-C Report. Clin Infect Dis. 2007;44(11):1524–5. - PubMed

[4] Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L, et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality—SEIFEM-C Report. Clin Infect Dis. 2007;44(11):1524–5. - PubMed

[5] Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011;66(Suppl 1):i5–14. - PubMed

[6] Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011;66(Suppl 1):i5–14. - PubMed

[7] Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis. 1995;171(6):1545–52. - PubMed

[8] Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis. 1995;171(6):1545–52. - PubMed

[9] Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;326(13):845–51. - PubMed

[10] Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;326(13):845–51. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The management of febrile neutropenia in the posaconazole era: a new challenge?

The management of febrile neutropenia in the posaconazole era: a new challenge?

Authors

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical